Prabesh Khatiwada
Overview
Explore the profile of Prabesh Khatiwada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khatiwada P, Rimal U, Han Z, Shemshedini L
Endocr Oncol
. 2024 Feb;
4(1):e230017.
PMID: 38410785
Androgen receptor (AR) and its constitutively active splice variant, AR Variant 7 (AR-V7), regulate genes essential for the development and progression of prostate cancer. Degradation of AR and AR-V7 by...
2.
Soni M, Migliori E, Fu J, Assal A, Chan H, Pan J, et al.
Front Immunol
. 2023 Oct;
14:1212203.
PMID: 37901229
T cell immunity plays a central role in clinical outcomes of Coronavirus Infectious Disease 2019 (COVID-19) and T cell-focused vaccination or cellular immunotherapy might provide enhanced protection for some immunocompromised...
3.
Khatiwada P, Rimal U, Malla M, Han Z, Shemshedini L
Endocr Oncol
. 2023 Oct;
3(1):e230010.
PMID: 37822366
Androgen receptor (AR) plays a vital role in the development and progression of prostate cancer from the primary stage to the usually lethal stage known as castration-resistant prostate cancer (CRPC)....
4.
Khatiwada P, Rimal U, Han Z, Malla M, Zhou J, Shemshedini L
Endocrinology
. 2023 Mar;
164(5).
PMID: 36951301
Prostate cancer transitions from an early treatable form to the lethal castration-resistant prostate cancer (CRPC). Androgen receptor (AR) and constitutively active AR splice variants, such as AR-V7, may be major...
5.
Soni M, Migliori E, Fu J, Assal A, Chan H, Pan J, et al.
bioRxiv
. 2023 Jan;
PMID: 36711835
T cell immunity plays a central role in clinical outcomes of Coronavirus Infectious Disease 2019 (COVID-19). Therefore, T cell-focused vaccination or cellular immunotherapy might provide enhanced protection for immunocompromised patients....
6.
Han Z, Rimal U, Khatiwada P, Brandman J, Zhou J, Hussain M, et al.
Endocrinology
. 2022 Oct;
164(1).
PMID: 36288553
Prostate cancer starts as a treatable hormone-dependent disease, but often ends in a drug-resistant form called castration-resistant prostate cancer (CRPC). Despite the development of the antiandrogens enzalutamide and abiraterone for...
7.
Khatiwada P, Kannan A, Malla M, Dreier M, Shemshedini L
PeerJ
. 2020 Apr;
8:e8921.
PMID: 32296610
Twist1, a basic helix-loop-helix transcription factor that regulates a number of genes involved in epithelial-to-mesenchymal transition (EMT), is upregulated in prostate cancer. Androgen regulation of Twist1 has been reported in...